Cargando…
Single sample pathway analysis in metabolomics: performance evaluation and application
BACKGROUND: Single sample pathway analysis (ssPA) transforms molecular level omics data to the pathway level, enabling the discovery of patient-specific pathway signatures. Compared to conventional pathway analysis, ssPA overcomes the limitations by enabling multi-group comparisons, alongside facili...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664704/ https://www.ncbi.nlm.nih.gov/pubmed/36376837 http://dx.doi.org/10.1186/s12859-022-05005-1 |
_version_ | 1784831155873251328 |
---|---|
author | Wieder, Cecilia Lai, Rachel P. J. Ebbels, Timothy M. D. |
author_facet | Wieder, Cecilia Lai, Rachel P. J. Ebbels, Timothy M. D. |
author_sort | Wieder, Cecilia |
collection | PubMed |
description | BACKGROUND: Single sample pathway analysis (ssPA) transforms molecular level omics data to the pathway level, enabling the discovery of patient-specific pathway signatures. Compared to conventional pathway analysis, ssPA overcomes the limitations by enabling multi-group comparisons, alongside facilitating numerous downstream analyses such as pathway-based machine learning. While in transcriptomics ssPA is a widely used technique, there is little literature evaluating its suitability for metabolomics. Here we provide a benchmark of established ssPA methods (ssGSEA, GSVA, SVD (PLAGE), and z-score) alongside the evaluation of two novel methods we propose: ssClustPA and kPCA, using semi-synthetic metabolomics data. We then demonstrate how ssPA can facilitate pathway-based interpretation of metabolomics data by performing a case-study on inflammatory bowel disease mass spectrometry data, using clustering to determine subtype-specific pathway signatures. RESULTS: While GSEA-based and z-score methods outperformed the others in terms of recall, clustering/dimensionality reduction-based methods provided higher precision at moderate-to-high effect sizes. A case study applying ssPA to inflammatory bowel disease data demonstrates how these methods yield a much richer depth of interpretation than conventional approaches, for example by clustering pathway scores to visualise a pathway-based patient subtype-specific correlation network. We also developed the sspa python package (freely available at https://pypi.org/project/sspa/), providing implementations of all the methods benchmarked in this study. CONCLUSION: This work underscores the value ssPA methods can add to metabolomic studies and provides a useful reference for those wishing to apply ssPA methods to metabolomics data. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12859-022-05005-1. |
format | Online Article Text |
id | pubmed-9664704 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-96647042022-11-15 Single sample pathway analysis in metabolomics: performance evaluation and application Wieder, Cecilia Lai, Rachel P. J. Ebbels, Timothy M. D. BMC Bioinformatics Research BACKGROUND: Single sample pathway analysis (ssPA) transforms molecular level omics data to the pathway level, enabling the discovery of patient-specific pathway signatures. Compared to conventional pathway analysis, ssPA overcomes the limitations by enabling multi-group comparisons, alongside facilitating numerous downstream analyses such as pathway-based machine learning. While in transcriptomics ssPA is a widely used technique, there is little literature evaluating its suitability for metabolomics. Here we provide a benchmark of established ssPA methods (ssGSEA, GSVA, SVD (PLAGE), and z-score) alongside the evaluation of two novel methods we propose: ssClustPA and kPCA, using semi-synthetic metabolomics data. We then demonstrate how ssPA can facilitate pathway-based interpretation of metabolomics data by performing a case-study on inflammatory bowel disease mass spectrometry data, using clustering to determine subtype-specific pathway signatures. RESULTS: While GSEA-based and z-score methods outperformed the others in terms of recall, clustering/dimensionality reduction-based methods provided higher precision at moderate-to-high effect sizes. A case study applying ssPA to inflammatory bowel disease data demonstrates how these methods yield a much richer depth of interpretation than conventional approaches, for example by clustering pathway scores to visualise a pathway-based patient subtype-specific correlation network. We also developed the sspa python package (freely available at https://pypi.org/project/sspa/), providing implementations of all the methods benchmarked in this study. CONCLUSION: This work underscores the value ssPA methods can add to metabolomic studies and provides a useful reference for those wishing to apply ssPA methods to metabolomics data. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12859-022-05005-1. BioMed Central 2022-11-14 /pmc/articles/PMC9664704/ /pubmed/36376837 http://dx.doi.org/10.1186/s12859-022-05005-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Wieder, Cecilia Lai, Rachel P. J. Ebbels, Timothy M. D. Single sample pathway analysis in metabolomics: performance evaluation and application |
title | Single sample pathway analysis in metabolomics: performance evaluation and application |
title_full | Single sample pathway analysis in metabolomics: performance evaluation and application |
title_fullStr | Single sample pathway analysis in metabolomics: performance evaluation and application |
title_full_unstemmed | Single sample pathway analysis in metabolomics: performance evaluation and application |
title_short | Single sample pathway analysis in metabolomics: performance evaluation and application |
title_sort | single sample pathway analysis in metabolomics: performance evaluation and application |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664704/ https://www.ncbi.nlm.nih.gov/pubmed/36376837 http://dx.doi.org/10.1186/s12859-022-05005-1 |
work_keys_str_mv | AT wiedercecilia singlesamplepathwayanalysisinmetabolomicsperformanceevaluationandapplication AT lairachelpj singlesamplepathwayanalysisinmetabolomicsperformanceevaluationandapplication AT ebbelstimothymd singlesamplepathwayanalysisinmetabolomicsperformanceevaluationandapplication |